This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-Aventis. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Innovator Tiborné Bai: Advancing Racemization Processes
Introduction: Tiborné Bai, an accomplished inventor based in Budapest, Hungary, has made significant contributions to the field of synthetic chemistry. With a focus on racemization processes, he has developed an innovative method that enhances the efficiency of producing optically active compounds used in therapeutic applications.
Latest Patents: Bai holds one patent titled "Process for Racemization." This invention pertains to the racemization process of the optically active [2-(2-thienyl)ethylamino](2-halogenophenyl)acetamides of general formula (VII) by utilizing basic compounds. The resulting racemic compounds can be efficiently recycled into the synthesis of therapeutically useful compounds represented by general formula (VI). This groundbreaking process reflects Bai's commitment to advancing medicinal chemistry.
Career Highlights: Bai is currently employed at Sanofi-Aventis, a leading global healthcare company dedicated to discovering and developing innovative medicines. His work within this esteemed organization highlights his significant role in the pharmaceutical industry, contributing to the development of better therapeutic solutions.
Collaborations: Throughout his career, Bai has collaborated with esteemed colleagues, including Mária Bakonyi and Zsolt Dombrády. These partnerships have allowed him to enhance his work and gain valuable insights from fellow experts in the field, thereby accelerating the pace of innovation in his research.
Conclusion: Tiborné Bai’s innovative work in the racemization process exemplifies the vital intersection of science and medicine. His patent not only contributes to the efficiency of drug synthesis but also underscores the importance of collaboration in driving forward advancements in the pharmaceutical industry. As a member of Sanofi-Aventis, Bai continues to make strides that positively impact the world of therapeutics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
